Oncimmune : PDMR / PCA Dealings

RNS Number : 0155G

Oncimmune Holdings PLC

12 March 2020

Oncimmune Holdings plc

("Oncimmune" or the "Company")

PDMR / PCA Dealings

Oncimmune Holdings plc (AIM: ONC.L), a leader in the development, manufacture and commercialisation of personalised immunodiagnostics for the screening, detection and care of cancer, has been notified that Geoffrey Hamilton-Fairley, PDMR and Non-Executive Vice Chairman, has transferred 1,907,220 ordinary shares of £0.01 each in the Company ("Ordinary Shares") for nil consideration to his wife (and person closely associated with him) Amanda Hamilton-Fairley on 9 March 2020.

The Company has also been notified that Amanda Hamilton-Fairley, sold 25,000 Ordinary Shares at a price of £0.70 per share on 10 March 2020.

Following this transaction, Geoffrey, together with his wife, have a total interest in the Company of 3,213,070 Ordinary Shares, representing approximately 5.08 per cent of the Company's issued Ordinary Share capital.

This announcement, including the notification below, is made in accordance with the requirements of Article 19 of the EU Market Abuse Regulation.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Geoffrey Hamilton-Fairley
2	Reason for the	notification
a)	Position/status	Non-Executive Vice Chairman
b)	Initial	Initial notification
	notification
	/Amendment
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer
	or auction monitor
a)	Name	Oncimmune Holdings plc
b)	LEI	213800HCYIWT6YPI1I02
4	Details of the	transaction(s): section to be repeated for (i) each type of instrument; (ii) each
	type of transaction; (iii) each date; and (iv) each place where transactions have been
	conducted
a)	Description of	Ordinary Shares of £0.01 each
	the financial
	instrument, type
	of instrument
	Identification	ISIN: GB00BYQ94H38
	code
b)	Nature of the	Transfer of shares
	transaction
c)	Price(s) and

	volume(s)
			Price		Volume
			Nil		1,907,220
d)	Aggregated
	information
	- Aggregated	Same as above
	volume
	- Price
e)	Date of the	9 March 2020
	transaction
f)	Place of the	London stock exchange, AIM
	transaction
	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Amanda Hamilton-Fairley
2	Reason for the	notification
a)	Position/status	Wife / PCA of Non-Executive Vice Chairman
b)	Initial	Initial notification
	notification
	/Amendment
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer
	or auction monitor
a)	Name	Oncimmune Holdings plc
b)	LEI	213800HCYIWT6YPI1I02
4	Details of the	transaction(s): section to be repeated for (i) each type of instrument; (ii) each
	type of transaction; (iii) each date; and (iv) each place where transactions have been
	conducted
a)	Description of	Ordinary Shares of £0.01 each
	the financial
	instrument, type
	of instrument
	Identification	ISIN: GB00BYQ94H38
	code
b)	Nature of the	Sale of shares
	transaction
c)	Price(s) and
	volume(s)
			Price		Volume
			0.70 GBP		25,000
d)	Aggregated
	information
	- Aggregated	Same as above
	volume
	- Price

e)	Date of the	10 March 2020
	transaction
f)	Place of the	London stock exchange, AIM
	transaction

For further information:

Oncimmune Holdings plc

Andrew Stewart, General Counsel and Company Secretary

[e-mail]

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] visit www.rns.com.

END

DSHEAPDAFDEEEFA